SelSym Biotech is a preclinical stage biotechnology startup located in North Carolina's Research Triangle developing novel platelet-mimetic therapeutics for the treatment of uncontrolled bleeding.
| Website | http://www.selsymbio.com |
| Employees | 9 (3 on RocketReach) |
| Founded | 2019 |
| Industry | Biotechnology |
| Keywords | Hemostasis, Biotechnology, Bleeding Disorders, Hematology, Thrombosis, Preclinical Stage, Therapeutic Agents, Novel Therapeutics, Drug Development, Drug Discovery, Biomedical Research, Biopharma, Pharmaceutical Research, Life Sciences, Clinical Trials, Pharmaceutical |
| Competitors | Thermo Fisher Scientific, Amgen, Roche, Genentech, Biogen, Novartis, Pfizer, Gilead Sciences, Bristol Myers Squibb, AbbVie +40 more (view full list) |
Looking for a particular SelSym Biotech employee's phone or email?
Seema Nandi is the Co-Founder and CEO of SelSym Biotech.
3 people are employed at SelSym Biotech.
SelSym Biotech is based in Raleigh, North Carolina.